Full articles are accessible by clicking on the title


Covid publications 

Non-Covid publications 


Covid publications

Non-Covid publications

Other publications of interest by PANDORA members

Covid publications

  • Sylverken AA, El-Duah P, Owusu M, Schneider J, Yeboah R, Ayisi-Boateng NK, Gorman R, Adu E, Kwarteng A, Frimpong M, Binger T, Aryeetey S, Asamoah JA, Amoako YA, Amuasi JH, Beheim-Schwarzbach J, Owusu-Dabo E, Adu-Sarkodie Y, Obiri-Danso K, Corman VM, Drosten C, Phillips R.
    Transmission of SARS-CoV-2 in northern Ghana: insights from whole-genome sequencing.
    Arch Virol. 2021 May;166(5):1385-1393. doi: 10.1007/s00705-021-04986-3. Epub 2021 Mar 15. PMID: 33723631; PMCID: PMC7959303.

Estimation of novel coronavirus (COVID-19) reproduction number and case fatality rate: A systematic review and meta-analysis.
Health Sci Rep. 2021 May 3;4(2):e274. doi: 10.1002/hsr2.274. PMID: 33977156; PMCID: PMC8093857.
  • Haque, M.F., Rahman, M.M., Alif, S.M., Akter, E., Barua, S., Paul, G.K. and Haider, N.
Global Biosecurity, 3(1), p.None. DOI:

Non-Covid publications

  • Bangura U, Buanie J, Lamin J, Davis C, Bongo GN, Dawson M, Ansumana R, Sondufu D, Thomson EC, Sahr F, Fichet-Calvet E.
Lassa Virus Circulation in Small Mammal Populations in Bo District, Sierra Leone.
Biology (Basel). 2021 Jan 5;10(1):28. doi: 10.3390/biology10010028. PMID: 33466234; PMCID: PMC7824740.
One Health Outlook. 2021;3(1):5. doi: 10.1186/s42522-021-00037-8. Epub 2021 Mar 22. PMID: 33778376; PMCID: PMC7982296.

Other publications of interest by PANDORA members-2021


Covid publications

  • Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, McHugh TD, Memish ZA,

Drosten C, Zumla A, Petersen E.

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.

Int J Infect Dis.2020 Feb;91:264-266. doi: 10.1016/j.ijid.2020.01.009. Epub 2020 Jan 14. PMID: 31953166

  • Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M.

Reducing mortality from 2019-nCoV: host-directed therapies should be an option. 

Lancet. 2020 Feb 22;395(10224):e35-e36. doi: 10.1016/S0140-6736(20)30305-6. Epub 2020 Feb 5. PMID: 32035018

  • Kock RA, Karesh WB, Veas F, Velavan TP, Simons D, Mboera LEG, Dar O, Arruda LB, Zumla A.

2019 -nCoV in context: lessons learned?

Lancet Planet Health. 2020 Mar;4(3):e87-e88. doi: 10.1016/S2542-5196(20)30035-8. Epub 2020 Feb 7. PMID: 32035507; PMCID: PMC7128686.

  • Ippolito G, Huis DS, Ntoumi F, Maeurer M, Zumla A.

Toning down the 2019-nCoV media hype—and restoring hope.

Lancet Respir Med. 2020 Mar;8(3):230-231. doi: 10.1016/S2213-2600(20)30070-9. Epub 2020 Feb 12. PMID: 32146924

  • Memish ZA, Perlman S, Van Kerkhove MD, Zumla A.

Middle East respiratory syndrome.

Lancet. 2020 Mar 28;395(10229):1063-1077. doi: 10.1016/S0140-6736(19)33221-0. Epub 2020 Mar 4. PMID: 32145185;

  • Haider N, Yavlinsky A, Simons D, Osman AY, Ntoumi F, Zumla A, Kock R.

Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America. 

Epidemiol Infect. 2020;148:e41. Published 2020 Feb 26. doi:10.1017/S0950268820000424. PMID: 32100667

  • Kapata N, Ihekweazu C, Ntoumi F, Tajudeen R, Chanda-Kapata P, Mwaba P, Mukonka V,

Bates M, Tembo J, Corman V, MfinangaS, AsogunD, Elton L, Arruda LB, Thomason MJ, Mboera L, Yavlinsky A, Haider N, Simons D, Hollmann L, Lule SA, Veas F, Hamid MMA, Dar O, Edwards SJL, Vairo F, McHugh TD, Drosten C, Kock R, Ippolito G, Zumla A.

Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic? - lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future

Int J Infect Dis. 2020 Apr;93:233-236. doi: 10.1016/j.ijid.2020.02.049. Epub 2020 Feb 28. PMID: 32119980;

  • Zumla A, Niederman MS.

The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security.

Curr Opin Pulm Med.  2020 May;26(3):193-196. doi: 10.1097/MCP.0000000000000676. PMID: 32132379;

  • Albarello F, Pianura E, Di Stefano F, Cristofaro M, Petrone A, Marchioni L, Palazzolo C,

Schininà V, Nicastri E, Petrosillo N, Campioni P, Petersen E, Zumla A, Ippolito G, COVID 19

INMI Study Group.

2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation

Int J Infect Dis. 2020 Apr;93:192-197. doi: 10.1016/j.ijid.2020.02.043. Epub 2020 Feb 26. PMID: 32112966; 

  • McCloskey B, Zumla A, Ippolito G, Blumberg L, Arbon P, Cicero A, Endericks T, Lim PL,

Borodina M, on behalf of the WHO Novel Coronavirus-19 Mass Gatherings Expert Group

Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma.

Lancet. 2020 Apr 4;395(10230):1096-1099. doi: 10.1016/S0140-6736(20)30681-4. Epub 2020 Mar 20. PMID: 32203693; 

  • Chanda-Kapata P, Kapata N, Zumla A,

COVID-19 and malaria: A symptom screening challenge for malaria endemic countries.

Int J Infect Dis. 2020 May;94:151-153. doi: 10.1016/j.ijid.2020.04.007. Epub 2020 Apr 27. PMID: 32344326;

  • Abena PM, Decloedt EH, Bottieau E, Suleman F, Adejumo P, Sam-Agudu NA, Muyembe TamFum JJ, Seydi M, Eholie SP, Mills EJ, Kallay O, Zumla A, Nachega JB.

Chloroquine and Hydroxychloroquine for the Prevention or Treatment of Novel CoronavirusDisease (COVID-19) in Africa: Caution for Inappropriate Off-Label Use in Healthcare Settings

Am J Trop Med Hyg. 2020 Jun;102(6):1184-1188. doi: 10.4269/ajtmh.20-0290. PMID: 32323646; 

  • Raoult D, Zumla A, Locatelli F, Ippolito G, Kroemer G.

Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses

Cell Stress. 2020 Mar 2;4(4):66-75. doi: 10.15698/cst2020.04.216. PMID: 32292881

  • Petersen E, McCloskey B, Hui DS, Kock R, Ntoumi F, Memish ZA, Kapata N, Azhar EI, Pollack M, Madoff LC, Hamer DH, Nachega JB, Pshenichnaya N, Zumla A

COVID-19 travel restrictions and the International Health Regulations - Call for an open debate on easing of travel restrictions.

Int J Infect Dis. 2020 Apr 17;94:88-90. doi: 10.1016/j.ijid.2020.04.029. PMID: 32305518 

  • McCloskey B, Zumla A, Lim PL, Endericks T, Arbon P, Cicero A, Borodina M

A risk-based approach is best for decision making on holding mass gathering events.

Lancet. 2020 Apr 18;395(10232):1256-1257. doi: 10.1016/S0140-6736(20)30794-7. Epub 2020 Apr 2. PMID: 32247321

  • Nachega JB, Seydi M, Zumla A.

The Late Arrival of COVID-19 in Africa - Mitigating Pan-Continental Spread

Clin Infect Dis. 2020 Jul 28;71(15):875-878. doi: 10.1093/cid/ciaa353. PMID: 32227121

  • Dexter D, Simons D, Kiyaga C, Kapata N, Ntoumi F, Kock R, Zumla A

Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries

Lancet Haematol. 2020 Jun;7(6):e430-e432. doi: 10.1016/S2352-3026(20)30122-8. Epub 2020 Apr 23. PMID: 32334676

  • Mehtar S, Preiser W, Lakhe NA, Bousso A, TamFum JM, Kallay O, Seydi M, Zumla A, Nachega JB.

Limiting the spread of COVID-19 in Africa: one size mitigation strategies do not fit all countries. 

Lancet Global Health. 2020 Jul;8(7):e881-e883. doi: 10.1016/S2214-109X(20)30212-6. Epub 2020 Apr 28. PMID: 32530422;

  • Velavan TP and Meyer CG.

Mild vs. Severe COVID19: Laboratory markers,

Int J Infect Dis. 2020 Jun;95:304-307. doi: 10.1016/j.ijid.2020.04.061. Epub 2020 Apr 25. PMID: 32344011;

  • Nachega JB, Leisegang R, Kallay O, Mills EJ, Zumla A, Lester RT.

Mobile Health Technology for Enhancing the COVID-19 Response in Africa: A Potential Game Changer?

Am J Trop Med Hyg. 2020 Jul;103(1):3-5. doi: 10.4269/ajtmh.20-0506. Epub 2020 May 29. PMID: 32476643;

  • Nachega JB, Grimwood A, Mahomed H, Fatti G, Preiser W, Kallay O, Mbala PK, Muyembe JT, Rwagasore E, Nsanzimana S, Ngamije D, Condo J, Sidat M, Noormahomed EV, Reid M, Lukeni B, Suleman F, Mteta A, Zumla A.

From Easing Lockdowns to Scaling-Up Community-Based COVID-19 Screening, Testing, and Contact Tracing in Africa - Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality.

Clin Infect Dis. 2020 May 31:ciaa695. doi: 10.1093/cid/ciaa695. Online ahead of print. PMID: 32474594

  • Aleksova A, Ferro F, Gagno G, Cappelletto C, Santon D, Rossi M, Ippolito G, Zumla A, Beltrami AP, Sinagra G.

COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?

J Intern Med. 2020 May 27:10.1111/joim.13101. doi: 10.1111/joim.13101. Epub ahead of print. PMID: 32459372; 

  • Carsetti R, Quintarelli C, Quinti I, Piano Mortari E, Zumla A, Ippolito G, Locatelli F.

The immune system of children: the key to understanding SARS-CoV-2 susceptibility?

Lancet Child Adolesc Health. 2020 Jun;4(6):414-416. doi: 10.1016/S2352-4642(20)30135-8. Epub 2020 May 6.PMID: 32458804

  • Messina F, Giombini E, Agrati C, Vairo F, Ascoli Bartoli T, Al Moghazi S, Piacentini M, Locatelli F, Kobinger G, Maeurer M, Zumla A, Capobianchi MR, Lauria FN, Ippolito G; COVID 19 INMI Network Study Group.

COVID-19: Viral-Host Interactome Analyzed by Network Based-Approach Model to Study Pathogenesis of SARS-CoV-2 Infection

J Transl Med. 2020 Jun 10;18(1):233. doi: 10.1186/s12967-020-02405-w. PMID: 32522207

  • Zumla A, Wang FS, Ippolito G, Petrosillo N, Agrati C, Azhar EI, El-Kafrawy SA, Osman M, Zitvogel L, Locatelli F, Gorman E, O'Kane C, Mcauley D, Maeurer M.

Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - achieving global consensus and visibility for cellular host-directed therapies.

Int J Infect Dis. 2020 Jul;96:431-439. doi: 10.1016/j.ijid.2020.05.040. Epub 2020 May 17. PMID: 32425638;

  • Bordoni V, Sacchi A, Cimini E, Notari S, Grassi G, Tartaglia E, Casetti R, Giancola L, Bevilacqua N, Maeurer M, Zumla A, Locatelli F, De Benedetti F, Palmieri F, Marchioni L, Capobianchi MR, D'Offizi G, Petrosillo N, Antinori A, Nicastri E, Ippolito G, Agrati C.

An Inflammatory Profile Correlates with Decreased Frequency of Cytotoxic Cells in COVID-19.

Clin Infect Dis. 2020 Nov 19;71(16):2272-2275. doi: 10.1093/cid/ciaa577. PMID: 32407466; PMCID: PMC7239202
  • Agrati C, Sacchi A, Bordoni V, Cimini E, Notari S, Grassi G, Casetti R, Tartaglia E, Lalle E, D'Abramo A, Castilletti C, Marchioni L, Shi Y, Mariano A, Song JW, Zhang JY, Wang Fu-S, Zhang C, Fimia GM, Capobianchi MR, Piacentini M, Antinori A, Nicastri E, Maeurer M, Zumla A, Ippolito G.

Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).

Cell Death Differ. 2020 Nov;27(11):3196-3207. doi: 10.1038/s41418-020-0572-6. Epub 2020 Jun 8. PMID: 32514047; PMCID: PMC7278239.

  • Velavan TP*, Pollard AJ, Kremsner PG.

Herd immunity and vaccination of children for COVID-19.

Int J Infect Dis. 2020. 2020 Sep;98:14-15. doi: 10.1016/j.ijid.2020.06.065. Epub 2020 Jun 23. PMID: 32585285

  • Velavan TP, Meyer CG.

The COVID‐19 epidemic.

Trop Med IntHealth.2020 Mar;25(3):278-280. doi: 10.1111/tmi.13383. Epub 2020 Feb 16.PMID: 32052514

  • Kapepula PM, Kabengele JK, Kingombe M, Van Bambeke F, Tulkens PM, Sadiki Kishabongo A, Decloedt E, Zumla A, Tiberi S, Suleman F, Tshilolo L, Muyembe-TamFum JJ, Zumla A, Nachega JB.

Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials.

Am J Trop Med Hyg. 2020 Sep;103(3):960-964. doi: 10.4269/ajtmh.20-0820.

PMID: 32705976

Advancing COVID-19 vaccines - avoiding different regulatory standards for different vaccines and need for open and transparent data sharing.

Int J Infect Dis. 2020 Sep;98:501-502. doi: 10.1016/j.ijid.2020.08.043. Epub 2020 Aug 19. PMID: 32822866

Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants.

Int J Infect Dis. 2020 Sep;98:454-459. doi: 10.1016/j.ijid.2020.07.016. Epub 2020 Jul 18. PMID: 32693089; 

  • Nachega JB, Mbala-Kingebeni P, Otshudiema J, Zumla A, Tam-Fum JM.

The colliding epidemics of COVID-19, Ebola, and measles in the Democratic Republic of the Congo.

Lancet Glob Health. 2020 Aug;8(8):e991-e992. doi: 10.1016/S2214-109X(20)30281-3. Epub 2020 Jun 23. PMID: 32589875

  • Ansumana R, Sankoh O, Zumla A.

Effects of disruption from COVID-19 on antimalarial strategies.

Nature Medicine. 2020 Sep;26(9):1334-1336. doi: 10.1038/s41591-020-1047-5. PMID: 32807937.

  • Zhang JY, Wang XM, Xing X, Xu Z, Zhang C, Song JW, Fan X, Xia P, Fu JL, Wang SY, Xu RN, Dai XP, Shi L, Huang L, Jiang TJ, Shi M, Zhang Y, Zumla A, Maeurer M, Bai F, Wang FS.

Single-cell landscape of immunological responses in patients with COVID-19.

Nature Immunology. 2020 Sep;21(9):1107-1118. doi: 10.1038/s41590-020-0762-x. Epub 2020 Aug 12.

PMID: 32788748

  • Meng F, Xu R, Wang S, Xu Z, Zhang C, Li Y, Yang T, Shi L, Fu J, Jiang T, Huang L, Zhao P, Yuan X, Fan X, Zhang JY, Song J, Zhang D, Jiao Y, Liu L, Zhou C, Maeurer M, Zumla A, Shi M, Wang FS.

Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial.

Nature - Signal Transduct Target Ther. 2020 Aug27;5(1):172. doi: 10.1038/s41392-020-00286-5.

PMID: 32855385

  • Song JW, Zhang C, Fan X, Meng FP, Xu Z, Xia P, Cao WJ, Yang T, Dai XP, Wang SY, Xu RN, Jiang TJ, Li WG, Zhang DW, Zhao P, Shi M, Agrati C, Ippolito G, Maeurer M, Zumla A, Wang FS, Zhang JY.

Immunological and inflammatory profiles in mild and severe cases of COVID-19.

Nature Communications. 2020 Jul 8;11(1):3410. doi: 10.1038/s41467-020-17240-2.

PMID: 32641700

  • Melenotte C, Silvin A, Goubet AG, Lahmar I, Dubuisson A, Zumla A, Raoult D, Merad M, Gachot B, Hénon C, Solary E, Fontenay M, André F, Maeurer M, Ippolito G, Piacentini M, Wang FS, Ginhoux F, Marabelle A, Kroemer G, Derosa L, Zitvogel L. 46.

Immune responses during COVID-19 infection.

Oncoimmunology. 2020 Aug 25;9(1):1807836. doi: 10.1080/2162402X.2020.1807836. PMID: 32939324

  • Nachega JB, Mbala-Kingebeni P, Otshudiema J, Mobula LM, Preiser W, Kallay O, Michaels-Strasser S, Breman JG, Rimoin AW, Nsio J, Ahuka-Mundeke S, Zumla A, Muyembe Tam-Fum JJ.

Responding to the Challenge of the Dual COVID-19 and Ebola Epidemics in the Democratic Republic of Congo-Priorities for Achieving Control.

Am J Trop Med Hyg. 2020 Aug;103(2):597-602. doi: 10.4269/ajtmh.20-0642. Epub 2020 Jun 19.

PMID: 32563272

  • Petersen E, Memish ZA, Zumla A, Maani AA.

Transmission of respiratory tract infections at mass gathering events.

Curr Opin Pulm Med. 2020 May;26(3):197-202. doi: 10.1097/MCP.0000000000000675.

PMID: 32149751

  • Zumla A, Marais BJ, McHugh TD, Maeurer M, Zumla A, Kapata N, Ntoumi F, Chanda-Kapata P, Mfinanga S, Centis R, Cirillo DM, Petersen E, Hui DS, Ippolito G, Leung CC, Migliori GB, Tiberi S.

COVID-19 and tuberculosis-threats and opportunities.

Int J Tuberc Lung Dis. 2020 Aug 1;24(8):757-760. doi: 10.5588/ijtld.20.0387.

PMID: 32912377

  • Haider N, Yavlinsky A, Chang YM, Hasan MN, Benfield C, Osman AY, Uddin MJ, Dar O, Ntoumi F, Zumla A, Kock R.

The Global Health Security index and Joint External Evaluation score for health preparedness are not correlated with countries' COVID-19 detection response time and mortality outcome.

Epidemiol Infect. 2020 Sep 7;148:e210. doi: 10.1017/S0950268820002046. PMID: 32892793.

  • Ansumana R, Sankoh O, Zumla A.

Effects of disruption from COVID-19 on antimalarial strategies.

Nat Med. 2020 Sep;26(9):1334-1336. doi: 10.1038/s41591-020-1047-5. PMID: 32807937.

  • Simulundu E, Mupeta F, Chanda-Kapata P, Saasa N, Changula K, Muleya W, Chitanga S, Mwanza M, Simusika P, Chambaro H, Mubemba B, Kajihara M, Chanda D, Mulenga L, Fwoloshi S, Shibemba AL, Kapaya F, Zulu P, Musonda K, Monze M, Sinyange N, Mazaba ML, Kapin'a M, Chipimo PJ, Hamoonga R, Simwaba D, Ngosa W, Morales AN, Kayeyi N, Tembo J, Bates M, Orba Y, Sawa H, Takada A, Nalubamba KS, Malama K, Mukonka V, Zumla A, Kapata N.
    First COVID-19 case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries.
    Int J Infect Dis. 2021 Jan;102:455-459. doi: 10.1016/j.ijid.2020.09.1480. Epub 2020 Oct 6. PMID: 33035675; PMCID: PMC7537667.
  • Haider N, Osman AY, Gadzekpo A, Akipede GO, Asogun D, Ansumana R, Lessells RJ, Khan P, Hamid MMA, Yeboah-Manu D, Mboera L, Shayo EH, Mmbaga BT, Urassa M, Musoke D, Kapata N, Ferrand RA, Kapata PC, Stigler F, Czypionka T, Zumla A, Kock R, McCoy D.
    Lockdown measures in response to COVID-19 in nine sub-Saharan African countries. 
    BMJ Glob Health. 2020 Oct;5(10):e003319. doi: 10.1136/bmjgh-2020-003319. PMID: 33028699; PMCID: PMC7542624.

Non-Covid publications-2020

  • Bomanji J, Sharma R, Mittal BR, Gambhir S, Qureshy A, Begum SMF, Paez D, Sathekge M,

Vorster M, Saranovic DS, Pusuwan P, Mann V, Vinjamuri S, Zumla A, Pascual TNB; ;

International Atomic Energy Agency Extra-pulmonary TB Consortium.

PET/CT features of extrapulmonary tuberculosis at first clinical presentation: a cross-sectional observational 18F-FDG imaging study across six countries. 

Eur Respir J.2020 Feb 27;55(2). pii: 1901959. doi: 10.1183/13993003.01959-2019. Print 2020 Feb. PMID: 31831584

  • Chakaya JM, Marais B, du Cros P, Ntoumi F, Mfinanga S, Kapata N, Hasnain SE,

Nathavitharana R, Zumla A.

Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis.

Lancet Respir Med. 2020 Apr;8(4):334-335. doi: 10.1016/S2213-2600(20)30104-1. Epub 2020 Feb 27. PMID: 32113573.

  • Tiberi S, Migliori GB, Muhwa Chakaya J, Kaesava T, Al Abri SS, Wejse C, Goletti D, Kapata N, Sotgiu G, Bomanji J, Zellweger JP, Hasan R, Irfan M, Ahmed I, Pshenichnaya N, Vasilieva I, Yeboah-Manu D, Alffenaar JW, Kim HY, Centis R, Cirillo DM, Alagna R, D'Ambrosio L, Cui X, Cao B, Maeurer M, Harries AD, Ippolito G, Raviglione M, Zumla A, Petersen E.
    Commemorating World TB Day 2020: "IT'S TIME" - It's time to End the Global TB Epidemic.
    Int J Infect Dis. 2020 Mar;92S:S1-S4. doi: 10.1016/j.ijid.2020.03.001. Epub 2020 Mar 4. PMID: 32145464.
  • Zumla A, Ippolito G, Ntoumi F, Seyfert-Margolies V, Nagu TJ, Cirillo D, Chakaya JM, Marais B,

Maeurer M.

Host-directed therapies and holistic care for tuberculosis.

Lancet Respir Med. 2020 Apr;8(4):337-340. doi: 10.1016/S2213-2600(20)30078-3. Epub 2020 Feb 27

  • Mwaba P, Chakaya JM, Petersen E, Wejse C, Zumla A, Kapata N.

Advancing New diagnostic tests for Latent TB infection due multi-drug resistant strains of Mycobacterium tuberculosis - End of the road?

Int J Infect Dis. 2020 Mar;92S:S69-S71. doi: 10.1016/j.ijid.2020.02.011. Epub 2020 Feb 28. PMID: 32119979

  • Priftakis D, Riaz S, Zumla A, Bomanji J.

Towards more accurate 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) imaging in active and latent tuberculosis.

Int J Infect Dis. 2020 Mar;92S:S85-S90. doi: 10.1016/j.ijid.2020.02.017. Epub 2020 Feb 27. PMID: 32114199.

  • Ihekweazu C, Yinka-Ogunleye A, Lule S, Ibrahim A.

Importance of epidemiological research of monkeypox: is incidence increasing?

Expert Rev Anti Infect Ther. 2020 May;18(5):389-392. doi: 10.1080/14787210.2020.1735361. Epub 2020 Mar 2. PMID: 32096659.

  • Yavlinsky A, Lule SA, Burns R, Zumla A, McHugh TD, Ntoumi F, Masanja H, Mwakasungula S,

Abubakar I, Aldridge RW.

Mobile-based and open-source case detection and infectious disease outbreak management systems; a review.

Wellcome Open Res. 2020, 5:37

  • Marais BJ, Chakaya J, Swaminathan S, Fox GJ, Ehtesham NZ, Ntoumi F, Maeurer M, Zumla A.

Tackling long-term morbidity and mortality after successful tuberculosis treatment

Lancet Infect Dis. 2020 Jun;20(6):641-642. doi: 10.1016/S1473-3099(20)30167-5. Epub 2020 Mar 23.

  • Zumla A, Yeboah-Manu D, Michel AL, Azhar EI, Torrelles JB, Cadmus SI, Kendall SL, Chakaya

JM, Marais B, Kock R.

Zoonotic tuberculosis-a call for an open One Health debate

Lancet Infect Dis. 2020 Jun;20(6):642-644. doi: 10.1016/S1473-3099(20)30166-3. Epub 2020 Mar 23. PMID: 32213331.

  • Sahu S, Ditiu L, Lawson L, Ntoumi F, Arakaki D, Zumla A.

UN General Assembly tuberculosis targets: are we on track?.

Lancet. 2020 Mar 21;395(10228):928-930. doi: 10.1016/S0140-6736(20)30565-1. PMID: 32199477.

  • Simulundu E, Ndashe K,Chambaro HM, Squarre D,Reilly PM, Chitanga S,Changula K, Mukubesa AN,Ndebe J, Tembo J, Kapata N, Bates M, Sinkala Y,Hang’ombe BM, Nalubamba KS, Kajihara M, Sasaki M, Orba Y, Takada A, Sawa H.

West Nile Virus in Farmed Crocodiles, Zambia, 2019.

Emerg Infect Dis. 2020 Apr;26(4):811-814. doi: 10.3201/eid2604.190954.PMID: 32187004

  • Danso EK, Asare P , Otchere ID , Akyeh LM , Asante-Poku A , Aboagye SY, Osei-Wusu S , Opare D , Ntoumi F, Zumla A , Duodu S, Yeboah-Manu D.

A Molecular and Epidemiological Study of Vibrio Cholerae Isolates From Cholera Outbreaks in Southern Ghana

PLoS One. 2020 Jul 10;15(7):e0236016. doi: 10.1371/journal.pone.0236016. eCollection 2020. PMID: 32649692;

  • Elton L , Thomason MJ , Tembo J, Velavan TP, Pallerla SR , Arruda LB , Vairo F , Montaldo C , Ntoumi F, Abdel Hamid MM , Haider N , Kock R , Ippolito G , Zumla A, McHugh TD, the PANDORA-ID-NET consortium

Antimicrobial resistance preparedness in sub-Saharan African countries

Antimicrob Resist Infect Control. 2020 Aug 28;9(1):145. doi: 10.1186/s13756-020-00800-y. PMID: 32859252;

Viruses. 2020 Sep 13;12(9):E1020. doi: 10.3390/v12091020. PMID: 32933109.

  • Haider N, Vairo F, Ippolito G, Zumla A, Kock RA.

Basic Reproduction Number of Chikungunya Virus Transmitted by Aedes Mosquitoes.

Emerg Infect Dis. 2020 Oct;26(10):2429-2431. doi: 10.3201/eid2610.190957. PMID: 32946722.

A Sporadic and Lethal Lassa Fever Case in Forest Guinea, 2019.

Viruses. 2020 Sep 23;12(10):E1062. doi: 10.3390/v12101062. PMID: 32977629.

  • Okoror L , Kapona O , Mpanga K., Tobin A, Asogun D.

Ebola Virus Diseasea Preparedness in Countries Bordering Democratic Republic of Congo: Lessons from West African Outbreak

African Journal of Infectious Diseases (AJID), 14(2), 36-41.

Tick Fauna and Associated RickettsiaTheileria, and Babesia spp. in Domestic Animals in Sudan (North Kordofan and Kassala States).
Microorganisms. 2020 Dec 11;8(12):E1969. doi: 10.3390/microorganisms8121969. PMID: 33322349.

Other publications of interest by PANDORA members-2020

  • Petersen E, Hui D, Hamer D, Blumberg L, Madoff L, Pollack M, Lee SS, McLellan S, Memish Z, Praharaj I, Wasserman S, Ntoumi F, Azhar EA, McHugh TD, Kock R, Ippolito G, Zumla A, Koopmans M.

Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak.

Int J Infect Dis 2020 Apr;93:205-207. doi: 10.1016/j.ijid.2020.02.052. Epub 2020 Mar 4. PMID: 32142979

  • Gualano G, Musso M, Mosti S, Mencarini P, Mastrobattista A, Pareo C, Zaccarelli M, Migliorisi P, Vittozzi P, Zumla A, Ippolito G, Palmieri F.

Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report.

Int J Infect Dis. 2020 Aug;97:174-176. doi: 10.1016/j.ijid.2020.05.027. Epub 2020 May 11. PMID: 32437932; PMCID: PMC7211646.

  • Mukonzo JK, Kengo A, Kutesa B, Nanzigu S, Pohanka A, McHugh TD, Zumla A, Aklillu E.

Role of pharmacogenetics in rifampicin pharmacokinetics and the potential effect on TB-rifampicin sensitivity among Ugandan patients. 

Trans R Soc Trop Med Hyg. 2020 Feb 7;114(2):107-114. doi: 10.1093/trstmh/trz108.PMID: 31789383

  • Marais BJ, Amanullah F, Gupta A, Becerra MC, Snow K, Ngadaya E, Sharma M, Hesseling AC,

Chakaya M, Zumla A.

Tuberculosis in children, adolescents, and women.

Lancet Respir Med. 2020 Apr;8(4):335-337. doi: 10.1016/S2213-2600(20)30077-1. Epub 2020 Feb 27. PMID: 32113571.

  • Hsu D, Irfan M, Jabeen K, Iqbal N, Hasan R, Migliori GB, Zumla A, Visca D, Centis R, Tiberi S.

Post tuberculosis treatment infectious complications

Int J Infect Dis. 2020 Mar;92S:S41-S45. doi: 10.1016/j.ijid.2020.02.032. Epub 2020 Feb 27. PMID: 32114203.


  • Ghoma Linguissi LS, Lucaccioni V, Bates M, Zumla A, Ntoumi F.

Achieving sustainable development goals for HIV/AIDS in the Republic of the Congo — Progress, obstacles and challenges in HIV/ AIDS health services

Int J Infect Dis. 2018 Dec;77:107-112. doi: 10.1016/j.ijid.2018.10.009. Epub 2018 Oct 17. PMID: 30342250.

  • Gualano G, Mencarini P, Lauria FN, Palmieri F, Mfinanga S, Mwaba P, Chakaya J, Zumla A, Ippolito G.

Tuberculin skin test – Outdated or still useful for Latent TB infection screening?

Int J Infect Dis. 2019 Mar;80S:S20-S22. doi: 10.1016/j.ijid.2019.01.048. Epub 2019 Feb 6. PMID: 30738186.

  • Honeyborne I, Lipman M, Zumla A, McHugh TD.

The changing treatment landscape for MDR/XDR-TB — Can current clinical trials revolutionise and inform a brave new world?

Int J Infect Dis. 2019 Mar;80S:S23-S28. doi: 10.1016/j.ijid.2019.02.006. Epub 2019 Feb 15. PMID: 30776547.

  • Kock RA, Haider N, Mboera LE, Zumla A.

A One-Health lens for anthrax.

Lancet Planet Health. 2019 Jul;3(7):e285-e286. doi: 10.1016/S2542-5196(19)30111-1. PMID: 31326067

  • Petersen E, Abubakar I, Ihekweazu C, Heymann D, Ntoumi F, Blumberg L, Asogun D, Mukonka V, Lule SA, Bates M, Honeyborne I, Mfinanga S, Mwaba P, Dar O, Vairo F, Mukhtar M, Kock R, McHugh TD, Ippolito G, Zumla A.

Monkeypox - Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era.

Int J Infect Dis. 2019; Jan;78:78-84. doi: 10.1016/j.ijid.2018.11.008. Epub 2018 Nov 16. Review.

PMID: 30453097

  • Rao M, Ippolito G, Mfinanga S, Ntoumi F, Yeboah-Manu D, Vilaplana C, Zumla A, Maeurer M.

Latent TB Infection (LTBI) – Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground

Int J Infect Dis. 2019 Mar; 80S:S58-S61. doi: 10.1016/j.ijid.2019.02.035. Epub 2019 Feb 26.

PMID: 30822547

  • Rao M, Ippolito G, Mfinanga S, Ntoumi F, Yeboah-Manu D, Vilaplana C, Zumla A, Maeurer M.

Improving treatment outcomes for MDR-TB — Novel host-directed therapies and personalised medicine of the future

Int J Infect Dis. 2019; 80S: Mar;80S:S62-S67. doi: 10.1016/j.ijid.2019.01.039. Epub 2019 Jan 24. PMID:30685590

  • Tembo J, Simulundu E, Changula K, Handley D, Gilbert M, Chilufya M, Asogun D, Ansumana

R, Kapata N, Ntoumi F, Ippolito G, Zumla A, Bates M.

Recent advances in the development and evaluation of molecular diagnostics for Ebola virus disease

Expert Rev Mol Diagn. 2019 Apr;19(4):325-340. doi: 10.1080/14737159.2019.1595592. Epub 2019 Apr 5. PMID: 30916590

  • Muneer A, Macrae B, Krishnamoorthy S, Zumla A.

Urogenital tuberculosis - epidemiology, pathogenesis and clinical features.

Nat Rev Urol. 2019 Oct;16(10):573-598. doi: 10.1038/s41585-019-0228-9. Epub 2019 Sep 23. PMID: 31548730.

  • Lanini S, Ioannidis JPA, Vairo F, Pletschette M, Portella G, Di Bari V, Mammone A, Pisapia R, Merler S, Nguhuni B, Langer M, Di Caro A, Edwards SJL, Petrosillo N, Zumla A, Ippolito G.

Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials.

Lancet Infect Dis. 2019 Dec;19(12):e444-e451. doi: 10.1016/S1473-3099(19)30284-1. Epub 2019 Aug 23.PMID: 31451421

  • Lalle E, Biava M, Nicastri E, Colavita F, Di Caro A, Vairo F, Lanini S, Castilletti C, Langer M,

Zumla A, Kobinger G, Capobianchi MR, Ippolito G.

Pulmonary Involvement during the Ebola Virus Disease.

Viruses. 2019 Aug 24 ;11(9). Pii : E780. Doi : 10.3390/v11090780. PMID: 3145059

  • Zumla A, Memish ZA.

Risk of antibiotic resistant meningococcal infections in Hajj pilgrims.

BMJ. 2019 Aug 23;366:l5260. Doi: 10.1136/bmj.l5260. PMID: 31444169.

  • Perlman S, Azhar EI, Memish ZA, Hui DS, Zumla A.

Confronting the persisting threat of the Middle East respiratory syndrome to global health security.

Lancet Infect Dis. 2020 Feb;20(2):158-160. doi: 10.1016/S1473-3099(19)30347-0. Epub 2019 Jul 3. PMID: 31279728; PMCID: PMC7128339.
  • Memish ZA, Steffen R, White P, Dar O, Azhar EI, Sharma A, Zumla A.

Mass gatherings medicine: public health issues arising from mass gathering religious and sporting events.

Lancet. 2019 May 18;393(10185):2073-2084. Doi: 10.1016/S0140-6736(19)30501-X. PMID: 31106753

  • Vairo F, Haider N, Kock R, Ntoumi F, Ippolito G, Zumla A.

Chikungunya– Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention.

Infect Dis Clin North Am. 2019 Dec;33(4):1003-1025. Doi: 10.1016/j.idc.2019.08.006. PMID: 31668189.

  • Nicastri E, Kobinger G, Vairo F, Montaldo C, Mboera L, Ansunama R, Zumla A, Ippolito G.

Ebola Virus Disease –Epidemiology, Clinical Features, Management, and Prevention.

Infect Dis Clin North Am. 2019 Dec;33(4):953-976. Doi: 10.1016/j.idc.2019.08.005. PMID: 31668200

  • Iannetta M, Di Caro A, Nicastri E, Vairo F, Masanja H, Kobinger G, Mirazimi A, Ntoumi F, Zumla A, Ippolito G.

Viral Hemorrhagic Fevers Other than Ebola and Lassa.

Infect Dis Clin N Am. 2019; 33: 977–10022019 Dec;33(4):977-1002. Doi: 10.1016/j.idc.2019.08.003. PMID: 31668201

  • Lanini S, Ustianowski A, Pisapia R, Zumla A, Ippolito G.

Viral Hepatitis– Etiology, Epidemiology, Transmission, Diagnostics, Treatment and Prevention.

Infect Dis Clin North Am. 2019 Dec;33(4):1045-1062.doi:10.1016/j.idc.2019.08.004.PMID:31668190

  • Asogun DA, Günther S, Akpede GO, Ihekweazu C, Zumla A.

Lassa Fever–Epidemiology, Clinical Features, Diagnosis, Management and Prevention

Infect Dis Clin N Am 2019; Dec;33(4):933-951. Doi: 10.1016/j.idc.2019.08.002. PMID: 31668199

  • Zumla A, Hui DSC.

Emerging and Re-emerging Infectious Diseases–Global Overview.

Infect Dis Clin North Am. 2019 Dec;33(4):xiii-xix. Doi: 10.1016/j.idc.2019.09.001. PMID: 31668202

  • Azhar EI, Hui DSC, Memish ZA, Drosten C, Zumla A.

The Middle East Respiratory Syndrome (MERS).

Infect Dis Clin North Am. 2019 Dec;33(4):891-905. Doi: 10.1016/j.idc.2019.08.001. PMID: 31668197

  • Hui DSC, Zumla A.

Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features.

Infect Dis Clin North Am. 2019 Dec;33(4):869-889. Doi: 10.1016/j.idc.2019.07.001. PMID: 31668196

  • Tiberi S, Zumla A, Migliori GB.

Multidrug and Extensively Drug-resistant Tuberculosis – Epidemiology, Clinical Features, Management and Treatment.

Infect Dis Clin North Am. 2019 Dec;33(4):1063-1085. Doi: 10.1016/j.idc.2019.09.002. PMID: 31668191

  • Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, Zumla A.

Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention.

Infect Dis Clin North Am. 2019 Dec;33(4):1027-1043. Doi: 10.1016/j.idc.2019.03.001. Epub 2019 Apr 11.PMID: 30981594

  • Mikounou VL, Nguekeng Tsague B, Ntoumi F, Vouvoungui C, Charles Kobawila S.

High prevalence of norovirus and rotavirus co-infection in children with acute gastroenteritis hospitalized in Brazzaville, Republic of Congo.

TropMed Int Health. 2019 Dec;24(12):1427-1433. Doi: 10.1111/tmi.13317. Epub 2019 Nov 28. PMID: 31627250

  • Mikounou Louya V, Vouvoungui C, Koukouikila-Koussounda F, Veas F, Kobawila SC, Ntoumi F.

Molecular characterization of norovirus infection responsible for acute diarrhea in Congolese hospitalized children under five years old in Brazzaville, Republic of Congo.

Int J Infect Dis. 2019 Nov ;88 :41-48. Doi : 10.1016/j.ijid.2019.07.034. Epub 2019 Aug 2. PMID : 31382046

  • Ntoumi F.

Supporting female scientists in Africa.

Lancet. 2019 Jun 1 ;393(10187) :2196. Doi : 10.1016/S0140-6736(19)31105-5. PMID : 31162075

  • Peko SM, Ntoumi F, Vouvoungui C, Nderu D, Kobawila SC, Velavan TP, Koukouikila-

Koussounda F.

Distribution of the cytochrome P450 CYP2C8*2 allele in Brazzaville, Republic of Congo.

Int J Infect Dis. 2019 Aug ;85 :49-53. Doi : 10.1016/j.ijid.2019.04.035. Epub 2019 May 9. PMID : 31078747

  • Mbouamboua Y, Koukouikila-Koussounda F, Ntoumi F, Adukpo S, Kombo M, Vouvoungui C,

van Helden J, Kobawila SC.

Sub-microscopic Plasmodium falciparum infections in matched peripheral, placental and umbilical cord blood samples from asymptomatic Congolese women at delivery.

Acta Trop. 2019 May ;193 :142-147. Doi : 10.1016/j.actatropica.2019.03.001. Epub 2019 Mar 2. PMID : 30836060

  • Gampio Gueye NS, Peko SM, Nderu D, Koukouikila-Koussounda F, Vouvoungui C, Kobawila

SC, Velavan TP, Ntoumi F.

An update on glucose-6-phosphate dehydrogenase deficiency in children from Brazzaville, Republic of Congo.

Malar J. 2019 Feb 28 ;18(1) :57. Doi : 10.1186/s12936-019-2688-z. PMID : 30819192

  • Peko SM, Gueye NSG, Vouvoungui C, Koukouikila-Koussounda F, Kobawila SC, Nderu D,

Velavan TP, Ntoumi F.

Cytochrome P450 CYP2B6*6 distribution among Congolese individuals with HIV, Tuberculosis and Malaria infection.

Int J Infect Dis. 2019 May ;82 :111-116. Doi : 10.1016/j.ijid.2019.02.025. Epub 2019 Feb 25.PMID : 30818046

  • Colavita F, Vairo F, Carletti F, Boccardo B, Ferraro F, Iaiani G, Al Moghazi S, Galardo G, Lalle E,

Selvaggi C, Scognamiglio P, Capobianchi MR, Ippolito G, Castilletti C.

Full-Length genome sequence of a dengue serotype 1 virus isolate from a traveler returning from Democratic Republic of Congo to Italy, July 2019.

Int J Infect Dis.2020 Mar ;92 :46-48. Doi : 10.1016/j.ijid.2019.12.023. Epub 2019 Dec 19.PMID : 31866548

  • El-Kafrawy SA, Corman VM, Tolah AM, Al Masaudi SA, Hassan AM, Müller MA, Bleicker T,

Harakeh SM, Alzahrani AA, Alsaaidi GA, Alagili AN, Hashem AM, Zumla A, Drosten C, Azhar EI.

Enzootic patterns of Middle East respiratory syndrome coronavirus in imported African and local Arabian dromedary camels : a prospective genomic study.

Lancet Planet Health. 2019 Dec;3(12):e521-e528. doi: 10.1016/S2542-5196(19)30243-8. Epub 2019 Dec 16. PMID: 31843456; PMCID: PMC6926486.


  • Abubakar I, Zumla A.

Universal health coverage for refugees and migrants in the twenty-first century

BMC Med. 2018 Nov 30;16(1):221. doi: 10.1186/s12916-018-1218-0. PMID: 30497477

  • Zumla A, Abubakar I.

Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants

BMC Med. 2018 Nov 30;16(1):221. doi: 10.1186/s12916-018-1218-0. PMID: 30497477

  • Edwards SJL, Norell CH, Illari P, Clarke B, Neuhaus CP.

A Radical Approach to Ebola: Saving Humans and Other Animals

Am J Bioeth. 2018 Oct;18(10):35-42. doi: 10.1080/15265161.2018.1513584. PMID: 30339070.